Cita APA

Marugan, C., Sanz-Gómez, N., Ortigosa, B., Monfort-Vengut, A., Bertinetti, C., Teijo, A., . . . Cárcer, G. d. (2024). TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling.

Citación estilo Chicago

Marugan, Carlos, et al. TPX2 Overexpression Promotes Sensitivity to Dasatinib in Breast Cancer By Activating YAP Transcriptional Signaling. 2024.

Cita MLA

Marugan, Carlos, et al. TPX2 Overexpression Promotes Sensitivity to Dasatinib in Breast Cancer By Activating YAP Transcriptional Signaling. 2024.